320 related articles for article (PubMed ID: 15130474)
41. Structure of a pseudo-16-mer DNA with stacked guanines and two G-A mispairs complexed with the N-terminal fragment of Moloney murine leukemia virus reverse transcriptase.
Coté ML; Georgiadis MM
Acta Crystallogr D Biol Crystallogr; 2001 Sep; 57(Pt 9):1238-50. PubMed ID: 11526315
[TBL] [Abstract][Full Text] [Related]
42. Reverse transcriptase. The use of cloned Moloney murine leukemia virus reverse transcriptase to synthesize DNA from RNA.
Gerard GF; Fox DK; Nathan M; D'Alessio JM
Mol Biotechnol; 1997 Aug; 8(1):61-77. PubMed ID: 9327398
[TBL] [Abstract][Full Text] [Related]
43. Recognition of internal cleavage sites by retroviral RNases H.
Schultz SJ; Zhang M; Champoux JJ
J Mol Biol; 2004 Nov; 344(3):635-52. PubMed ID: 15533434
[TBL] [Abstract][Full Text] [Related]
44. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase.
Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG
Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812
[TBL] [Abstract][Full Text] [Related]
45. Crystal structure of the moloney murine leukemia virus RNase H domain.
Lim D; Gregorio GG; Bingman C; Martinez-Hackert E; Hendrickson WA; Goff SP
J Virol; 2006 Sep; 80(17):8379-89. PubMed ID: 16912289
[TBL] [Abstract][Full Text] [Related]
46. Elucidation of the role of Arg 110 of murine leukemia virus reverse transcriptase in the catalytic mechanism: biochemical characterization of its mutant enzymes.
Chowdhury K; Kaushik N; Pandey VN; Modak MJ
Biochemistry; 1996 Dec; 35(51):16610-20. PubMed ID: 8987996
[TBL] [Abstract][Full Text] [Related]
47. An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer.
Misra HS; Pandey PK; Pandey VN
J Biol Chem; 1998 Apr; 273(16):9785-9. PubMed ID: 9545316
[TBL] [Abstract][Full Text] [Related]
48. Selective inactivation of M-MuLV RT RNase H activity by site-directed PEGylation: an improved ability to synthesize long cDNA molecules.
Radzvilavicius T; Lagunavicius A
N Biotechnol; 2012 Feb; 29(3):285-92. PubMed ID: 21807127
[TBL] [Abstract][Full Text] [Related]
49. Direct observation of reverse transcriptases by scanning tunneling microscopy.
Lewerenz HJ; Jungblut H; Campbell SA; Giersig M; Müller DJ
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1663-7. PubMed ID: 1280957
[TBL] [Abstract][Full Text] [Related]
50. Structural alterations in the DNA ahead of the primer terminus during displacement synthesis by reverse transcriptases.
Winshell J; Champoux JJ
J Mol Biol; 2001 Mar; 306(5):931-43. PubMed ID: 11237609
[TBL] [Abstract][Full Text] [Related]
51. Cloning, expression, and purification of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase: crystallization of nucleic acid complexes.
Sun D; Jessen S; Liu C; Liu X; Najmudin S; Georgiadis MM
Protein Sci; 1998 Jul; 7(7):1575-82. PubMed ID: 9684890
[TBL] [Abstract][Full Text] [Related]
52. RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.
Telesnitsky A; Goff SP
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1276-80. PubMed ID: 7679498
[TBL] [Abstract][Full Text] [Related]
53. RNA-binding and viral reverse transcriptase inhibitory activity of a novel cationic diamino acid-based peptide.
Roviello GN; Di Gaetano S; Capasso D; Franco S; Crescenzo C; Bucci EM; Pedone C
J Med Chem; 2011 Apr; 54(7):2095-101. PubMed ID: 21391685
[TBL] [Abstract][Full Text] [Related]
54. Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H.
Schultz SJ; Zhang M; Champoux JJ
J Mol Biol; 2010 Mar; 397(1):161-78. PubMed ID: 20122939
[TBL] [Abstract][Full Text] [Related]
55. Insight into the mechanism of the stabilization of moloney murine leukaemia virus reverse transcriptase by eliminating RNase H activity.
Mizuno M; Yasukawa K; Inouye K
Biosci Biotechnol Biochem; 2010; 74(2):440-2. PubMed ID: 20139597
[TBL] [Abstract][Full Text] [Related]
56. The solution structure of the simian foamy virus protease reveals a monomeric protein.
Hartl MJ; Wöhrl BM; Rösch P; Schweimer K
J Mol Biol; 2008 Aug; 381(1):141-9. PubMed ID: 18597783
[TBL] [Abstract][Full Text] [Related]
57. Expression of moloney murine leukemia virus reverse transcriptase in a cell-free protein expression system.
Katano Y; Hisayoshi T; Kuze I; Okano H; Ito M; Nishigaki K; Takita T; Yasukawa K
Biotechnol Lett; 2016 Jul; 38(7):1203-11. PubMed ID: 27053084
[TBL] [Abstract][Full Text] [Related]
58. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
Loya S; Hizi A
J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
[TBL] [Abstract][Full Text] [Related]
59. Determination of the site of first strand transfer during Moloney murine leukemia virus reverse transcription and identification of strand transfer-associated reverse transcriptase errors.
Kulpa D; Topping R; Telesnitsky A
EMBO J; 1997 Feb; 16(4):856-65. PubMed ID: 9049314
[TBL] [Abstract][Full Text] [Related]
60. Comparison of M-MLV reverse transcriptase and Tth polymerase activity in RT-PCR of samples with low virus burden.
Cusi MG; Valassina M; Valensin PE
Biotechniques; 1994 Dec; 17(6):1034-6. PubMed ID: 7532975
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
